If you have completed our form and received a confirmation of your access please sign-in to your account to view.
Otherwise, and if you are a AHPRA accredited pharmacists, please complete our Pharmacist Access Application form for access.
AHPRA accredited pharmacists only.
*Available to order by AHPRA accredited pharmacists only.
AHPRA accredited pharmacists only. Complete our customer approval form and once approved you’ll have access to detailed product information, pharmacist resources and purchase options.
Deliveries are scheduled from Monday to Thursday. To ensure the integrity of our cold chain solution, we do not deliver on Fridays. For metro areas, delivery is expected within 24 hours. For regional areas, delivery times vary but typically take between 48-72 hours. Please note these are estimates only. All shipments adhere to Good Distribution Practices (GDP) to maintain product integrity.
Cryosite adhere to strict quality assurance measures to ensure the safety and efficacy of all goods. This includes regular inspections, monitoring of temperature data, and compliance with regulatory guidelines.
We have partnered with Cryosite, a company specialising in the storage and transport of temperature-sensitive products, including biologics and vaccines. Cryosite's services comply with Good Distribution Practices (GDP) and include validated storage and transportation solutions to maintain temperature integrity, ensuring the safety and efficacy of our products.
You can contact our customer support team via email at enquiries@supamed.com.au or by phone at 1300 186 653.
Our support team is available to assist you with any questions or concerns.
Yes. This product is manufactured in Novo Nordisk manufacturing facilities for the German Market and has been purchased from accredited German distributors by Cole Supplies.
Yes. The CMI is in German, however, we provide all pharmacists with a "Letter to Customer" to explain why this is and how to access the English version.
The Section 19A products OZEMPIC (semaglutide) 0.25 mg solution for injection pre-filled pen (Germany) and OZEMPIC (semaglutide) 0.5 mg solution for injection pre-filled pen (Germany) have been approved for use with the same indications and route of administration as the Australian registered product OZEMPIC 0.25/0.5 mg semaglutide (rys) 1.34 mg/mL solution for injection pre-filled pen.
These Section 19A Ozempic products are registered and marketed in Germany by Novo Nordisk A/S, so all the original labelling is in German. However, for your convenience, both Section 19A Ozempic products will be over-labelled in English.
Using Ozempic® (Semaglutide) may cause mild-to-moderate digestive discomforts such as nausea, vomiting, and diarrhea, which are typically temporary. Some people may also experience local reactions at the injection site, such as redness, swelling, or itching, and in rare instances, allergic responses. Other common side effects include reflux, abdominal pain, and fatigue.
In some patient groups, Ozempic® (Semaglutide) may increase the incidence of retinopathy (eye disease) complications.
It is important to be aware of the potential side effects of Ozempic® (Semaglutide) and to consult with your doctor if you experience any of these side effects.
If a patient experiences severe side effects or an allergic reaction, they should seek immediate medical attention and contact their healthcare provider.
Ozempic® (semaglutide) injection 0.25 mg or 0.5 mg is an injectable prescription medicine used:
Do not use the Ozempic® pen if it has been frozen. Dispose of the pen according to local regulations and use a new pen.
Certified Cold Chain Freight (stored at 2°C to 8°C)
Packing details:
0.5mg 1 pk: Ctn – 66x49x62cm 14kg
0.25mg 1 pk: Ctn – 66x49x62cm 14kg
0.5mg 3 pk: Ctn – 66x49x62cm 12kg
Labelling: English over-label
Minimum Order Quantity: 1 carton of 180 units
Yes. Disinfect the injection site with an alcohol pad before use. After administering Ozempic®, dispose of the pen and needles responsibly in an appropriate sharps container.
Between or 2°C to 8°C.
For users: After the first use, you can store your pen at room temperature (between 15ºC to 30ºC) or continue keeping it in the refrigerator. Dispose of the pen after 56 days, regardless of whether it was stored in the refrigerator or at room temperature, even if there is medicine left in it. Do not use the Ozempic® pen if it has been frozen. Avoid keeping your pens in the car, as they may get too hot or too cold.
Do not share your Ozempic® pen with other people, even if the needle has been changed. You may give other people a serious infection, or get a serious infection from them.
What is the most important information I should know about Ozempic®?
Ozempic® may cause serious side effects, including:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, herbal supplements, and other medicines to treat diabetes, including insulin or sulfonylureas.
We provide TGA-approved Patient Health Care Professional letters for your use.
Cole supplies has TGA authorisation to distribute Ozempic. See below for links to relevant TGA documentation.
OZEMPIC semaglutide 0.25mg solution for injection pre-filled
pen: https://www.tga.gov.au/resources/section-19a-approvals/ozempic-semaglutide-025mg-solution-injection-pre-filled-pen-germany-0
OZEMPIC semaglutide 0.5mg solution for injection pre-filled pen: https://www.tga.gov.au/resources/section-19a-approvals/ozempic-semaglutide-05mg-solution-injection-pre-filled-pen-germany
Please click here Consumer Medicine Information (CMI) summary, Prescribing Information and Medication Guide for Ozempic®.
For detailed product information, services, and resources to support your practice click here.